from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2363/amiA2

LFCtreatmentdescriptionclass of inhibitor

0.511

Amikacinug/mL Amikacintranslation

1.018

Cap5-10ug/mL Capreomycintranslation

2.010

Rox10-50 ug/mL Roxithromycintranslation

0.006

SM2-5 ug/mL Streptomycintranslation

-0.510

Tet5-10 ug/mL Tetracyclinetranslation

0.880

Rif0.2-5ug/mL Rifampicintranscription

-0.343

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.563

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.910

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.861

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.591

Clofazimine10-13 ug/mL Clofaziminerespiration

0.266

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.391

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.738

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.359

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.029

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-2.111

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.181

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.892

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.179

KCN5-20 ug/mL Potassium cyaniderespiration

-0.702

NaN30.2-2 mM Sodium aziderespiration

0.476

Nigericin50 uM Nigericinrespiration

-0.639

TRC10-150 ug/mL Triclosanrespiration

-0.929

TRZ10-25 ug/mL Thioridazinerespiration

-0.201

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.920

menadione6-10 ug/mL Menadionerespiration

-0.263

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.596

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.095

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.583

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.247

NRP_1Non-replicating persistence stage 1dosRassociated

0.419

Amp0.2mg/mL AmpicillincellWall

0.309

Cephalexin20-100 ug/mL CephalexincellWall

0.752

Cerulenin0.32-5 ug/mL CerulenincellWall

0.672

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.470

EMB10-20 ug/mL EthambutolcellWall

0.305

Eta12-40 ug/mL EthionamidecellWall

0.610

INH0.2-0.4 ug/mL IsoniazidcellWall

0.442

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.336

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.476

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.795

BZA0.12 mg/mL BenzamidearomaticAmides

0.321

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.483

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.344

H2O24 mM hydrogen peroxideDNAdamaging

0.357

Levo10 ug/mL LevofloxacinDNAdamaging

0.404

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.010

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.367

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.689

UVUV-irradiationDNAdamaging

-1.146

ARP41-4 ug/mL Antitubercular compound ARP4?

0.557

Antimycin12.5-50 ug/mL Antimycin A?

0.494

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.277

PA_110-50 ug/mL Antitubercular compound PA-1?

0.109

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.352

PA8240.2-2 ug/mL PA-824?

-1.212

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.021

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.346

Verapamil50 uM Verapamil?

-0.093

mercaptoethanol2 mM 2-Mercaptoethanol?

0.448

methoxatin10-20 ug/mL Methoxatin?